Medical Economics Expert Panel 12.2
|Articles|September 18, 2009

Survey: Physicians confused about off-label drug use

Nearly half of physicians believe that various off-label uses of prescription drugs are approved by the Food and Drug Administration, according to a national survey.

Nearly half of physicians believe that various off-label uses of prescription drugs are approved by the Food and Drug Administration, according to a national survey. Overall, only 55 percent of physicians correctly identified the indicated FDA-approval status of the 22 drugs that were included in the survey, the results of which were published in the August issue of Pharmacoepidemiology and Drug Safety.

In many cases, the proportion of physicians who erroneously believed a particular drug was FDA approved for a specific indication was higher among physicians who had prescribed the drug for that indication.


Related to this article

Vincent Cantone: ©WellSpan Health
With projected shortfalls of 86,000 to more than 187,000 physicians within a decade, burnout, an aging workforce and capped residency slots are squeezing supply. Here are the training, payment, prior authorization and workplace changes that could help close the gap.
Qasim Faizan: ©WeBill Health
Starting Jan. 1, Medicare will pay 20% less for the lower-valued service when an office visit billed with modifier 25 falls on the same day as a zero-day global procedure. One claims report priced at local 2027 rates shows independent practices their exposure, and three documentation habits protect the visits that still qualify for full payment.